Vascular BioSciences (VBS) is a biopharmaceutical and medical device company focused on developing solutions for difficult-to-treat cardiovascular and inflammatory diseases – the leading cause of serious illness and death in industrialized countries. VBS is currently fast-tracking a treatment to improve survival in critically ill COVID-19 patients.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
1995
Main Therapeutic Focus:
Inflammation
Lead Product in Development:
CAR Peptide as a Treatment to Improve Survival in Critically ill COVID-19 Patients
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
